Published in Front Oncol on October 26, 2016
Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet (1998) 10.11
Distinct stem cells contribute to mammary gland development and maintenance. Nature (2011) 6.32
Age at first birth and breast cancer risk. Bull World Health Organ (1970) 6.16
Control of mammary stem cell function by steroid hormone signalling. Nature (2010) 5.38
Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst (2006) 5.12
Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol (2010) 3.75
The endocrinology of aging. Science (1997) 3.28
Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat (1982) 2.98
Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb Perspect Biol (2011) 2.48
Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-beta1 expression. Oncogene (2005) 2.37
Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older. J Clin Oncol (2011) 2.00
Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells--implications for pregnancy-induced protection against breast cancer. Stem Cells (2008) 1.96
Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas. Cancer Epidemiol Biomarkers Prev (2008) 1.88
Lactation and reproductive histories of breast cancer patients in Tokyo, Japan. Bull World Health Organ (1970) 1.85
Biological and molecular bases of mammary carcinogenesis. Lab Invest (1987) 1.79
Pregnancy and the risk of breast cancer. Endocr Relat Cancer (2007) 1.72
The GH/IGF-1 axis in ageing and longevity. Nat Rev Endocrinol (2013) 1.68
Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev (1994) 1.68
Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res (1988) 1.68
Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women. Cancer Epidemiol Biomarkers Prev (2010) 1.66
Long-term risk of malignant neoplasm associated with gestational glucose intolerance. Cancer (2004) 1.59
Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Mol Endocrinol (2002) 1.56
Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci U S A (1999) 1.56
Influence of age and parity on the development of the human breast. Breast Cancer Res Treat (1992) 1.54
Susceptibility of the mammary gland to carcinogenesis. II. Pregnancy interruption as a risk factor in tumor incidence. Am J Pathol (1980) 1.54
Mammary developmental fate and breast cancer risk. Endocr Relat Cancer (2005) 1.53
Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2005) 1.50
Microenvironment of the involuting mammary gland mediates mammary cancer progression. J Mammary Gland Biol Neoplasia (2007) 1.50
Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epithelium. Breast Cancer Res (2013) 1.49
Pregnancy characteristics and maternal risk of breast cancer. Epidemiology (1998) 1.48
Reproductive history and risk of three breast cancer subtypes defined by three biomarkers. Cancer Causes Control (2010) 1.33
Global changes in the mammary epigenome are induced by hormonal cues and coordinated by Ezh2. Cell Rep (2013) 1.33
Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats. Carcinogenesis (1998) 1.31
Gene expression patterns in the human breast after pregnancy. Cancer Prev Res (Phila) (2010) 1.31
Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev (2002) 1.31
Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res (2006) 1.30
Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia? Carcinogenesis (1995) 1.29
Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cells. Breast Cancer Res (2009) 1.25
First pregnancy characteristics and subsequent breast cancer risk among young women. Int J Cancer (2004) 1.23
Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. Cancer Res (2000) 1.21
Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age. Int J Cancer (2003) 1.18
Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. Breast Cancer Res (2010) 1.16
Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies. Cancer (2009) 1.16
Stiff collagen matrices increase tumorigenic prolactin signaling in breast cancer cells. J Biol Chem (2013) 1.15
Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. Cell Stem Cell (2013) 1.14
Collagen architecture in pregnancy-induced protection from breast cancer. J Cell Sci (2013) 1.12
Diabetes increases the risk of breast cancer: a meta-analysis. Endocr Relat Cancer (2012) 1.12
Short-term exposure to pregnancy levels of estrogen prevents mammary carcinogenesis. Proc Natl Acad Sci U S A (2001) 1.11
First births to older women continue to rise. NCHS Data Brief (2014) 1.11
Chemical carcinogen-induced tumorigenesis in parous, involuted mouse mammary glands. J Natl Cancer Inst (1999) 1.06
A systematic review of the association between breastfeeding and breast cancer. J Womens Health (Larchmt) (2008) 1.04
The growth hormone-deficient Spontaneous Dwarf rat is resistant to chemically induced mammary carcinogenesis. Carcinogenesis (2002) 1.02
The epigenetic landscape of mammary gland development and functional differentiation. J Mammary Gland Biol Neoplasia (2010) 1.02
Architectural pattern of the normal and cancerous breast under the influence of parity. Cancer Epidemiol Biomarkers Prev (1994) 0.99
Expression of phenotypical changes by human breast epithelial cells treated with carcinogens in vitro. Cancer Res (1988) 0.99
SOM230 inhibits insulin-like growth factor-I action in mammary gland development by pituitary independent mechanism: mediated through somatostatin subtype receptor 3? Mol Endocrinol (2005) 0.98
Defining the genomic signature of the parous breast. BMC Med Genomics (2012) 0.97
Hormone-related risk factors and postmenopausal breast cancer among nulliparous versus parous women: An aggregated study. Am J Epidemiol (2011) 0.96
Changes in the parous rat mammary gland environment are involved in parity-associated protection against mammary carcinogenesis. Anticancer Res (1999) 0.95
Grand multiparity and the risk of breast cancer: population-based study in Finland. Cancer Causes Control (2001) 0.95
Effects of age and parity on mammary gland lesions and progenitor cells in the FVB/N-RC mice. PLoS One (2012) 0.94
Advanced rat mammary cancers are growth hormone dependent. Endocrinology (2007) 0.92
How pregnancy at early age protects against breast cancer. Trends Mol Med (2013) 0.92
IGF-I during primiparous pregnancy and maternal risk of breast cancer. Breast Cancer Res Treat (2009) 0.92
Maternal plasma concentrations of IGF-1, IGFBP-1, and C-peptide in early pregnancy and subsequent risk of gestational diabetes mellitus. Am J Obstet Gynecol (2005) 0.91
Lactation and breast cancer risk: a case-control study in Connecticut. Br J Cancer (2001) 0.90
Insulin-like growth factor (IGF)-I obliterates the pregnancy-associated protection against mammary carcinogenesis in rats: evidence that IGF-I enhances cancer progression through estrogen receptor-alpha activation via the mitogen-activated protein kinase pathway. Breast Cancer Res (2004) 0.90
Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II. Breast Cancer Res (2012) 0.88
Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling. Breast Cancer Res (2014) 0.88
Gestational diabetes and the risk of breast cancer among women in the Jerusalem Perinatal Study. Breast Cancer Res Treat (2007) 0.87
Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol (1997) 0.86
Insulin, insulin-like growth factor-1, and insulin resistance in women with pregnancy-induced hypertension. Am J Obstet Gynecol (2002) 0.86
Mammary tumorigenesis in growth hormone deficient spontaneous dwarf rats; effects of hormonal treatments. Breast Cancer Res Treat (2004) 0.86
The relationship between preeclampsia, pregnancy-induced hypertension and maternal risk of breast cancer: a meta-analysis. Acta Oncol (2012) 0.86
Parity-induced decrease in systemic growth hormone alters mammary gland signaling: a potential role in pregnancy protection from breast cancer. Cancer Prev Res (Phila) (2010) 0.85
Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia. Obstet Gynecol (2001) 0.85
Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells. PLoS One (2015) 0.85
Levels of insulin-like growth factor during pregnancy and maternal cancer risk: a nested case-control study. Cancer Causes Control (2011) 0.85
Mean Age of Mothers is on the Rise: United States, 2000-2014. NCHS Data Brief (2016) 0.84
A longitudinal study of maternal plasma insulin-like growth factor binding protein-1 concentrations during normal pregnancy and pregnancies complicated by pre-eclampsia. Hum Reprod (2000) 0.84
Gestational diabetes and risk of incident primary cancer: a large historical cohort study in Israel. Cancer Causes Control (2011) 0.84
Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status. Breast Cancer Res (2014) 0.84
Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia. Pituitary (2011) 0.83
Pregnancy-induced chromatin remodeling in the breast of postmenopausal women. Int J Cancer (2012) 0.83
Maternal plasma concentrations of insulinlike growth factor-1 and insulinlike growth factor-binding protein-1 in early pregnancy and subsequent risk of preeclampsia. Clin Biochem (2004) 0.83
Pregnancy-related characteristics and breast cancer risk. Cancer Causes Control (2013) 0.83
Relationships between critical period of estrogen exposure and circulating levels of insulin-like growth factor-I (IGF-I) in breast cancer: evidence from a case-control study. Int J Cancer (2010) 0.82
Mimicking pregnancy as a strategy for breast cancer prevention. Breast Cancer Manag (2013) 0.82
Short-term risk of cancer among women with previous gestational diabetes: a population-based study. Diabet Med (2015) 0.81
A morphological study of the changes which occur during pregnancy in the human breast. Virchows Arch A Pathol Anat Histopathol (1983) 0.81
Mammary gland morphological and gene expression changes underlying pregnancy protection of breast cancer tumorigenesis. Physiol Genomics (2011) 0.81
Reproduction and breast cancer risk. Breast Care (Basel) (2014) 0.80
Serum levels of insulin, IGF-1, and IGFBP-1 in pre-eclampsia and eclampsia. Int J Gynaecol Obstet (2004) 0.80
Insulin-Like Growth Factor Axis and Gestational Diabetes Mellitus: A Longitudinal Study in a Multiracial Cohort. Diabetes (2016) 0.79
Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial. Breast Cancer Res (2014) 0.79
Breastfeeding reduces breast cancer risk: a case-control study in Tunisia. Cancer Causes Control (2010) 0.79
Ramazzini and Rigoni-Stern on parity and breast cancer. Clinical impression and statistical corroboration. Arch Intern Med (1961) 0.79
Targeted DNA Methylation Screen in the Mouse Mammary Genome Reveals a Parity-Induced Hypermethylation of Igf1r That Persists Long after Parturition. Cancer Prev Res (Phila) (2015) 0.78
Changes in circulating level of IGF-I and IGF-binding protein-1 from the first to second trimester as predictors of preeclampsia. Eur J Endocrinol (2008) 0.78
Serum insulin-like growth factors in normal pregnancy and in pregnancies complicated by preeclampsia. Acta Obstet Gynecol Scand (2003) 0.77